COMPANY PROFILE

Valink Therapeutics

Explore full profile

Creating custom biologics using a modular approach

London, United KingdomFounded 2021Biotech & Life Sciences

Valuation $25–50M Last recorded · 2025

Revenue <$1M Latest reported FY

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Valink Therapeutics

Valink Therapeutics is a biotechnology company specializing in the development of bispecific antibody drug conjugates for the treatment of solid tumors. The company leverages its proprietary 5D Combinatorial Drug Discovery Platform to rapidly design and build libraries of drug candidates using modular components such as antibody fragments and small molecules. This approach allows for the creation of next-generation cancer treatments that are both specific and effective, targeting two cellular markers simultaneously to distinguish malignant from healthy tissue. Valink Therapeutics serves the oncology market, focusing on providing innovative solutions for cancer treatment. The business model involves the development and commercialization of these advanced therapeutics, generating revenue through partnerships, licensing agreements, and direct sales.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2021
Headquarters: London, United Kingdom
Employees: 32
Open positions: 1
Dealroom signal: 88.7/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Drug Development, Core AI, Spinout, Tech for Biotech and Pharma, AI Drug Discovery, BIA Techbio UK
Technology: Artificial Intelligence, Deep Tech
Business model: SaaS
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

5 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
EARLY VC✓Equity / VC	Oct 2025	$12M	$46M	Hoxton Ventures · Redalpine · Oxford Science Enterprises · RV Invest	↗
EARLY VC✓Equity / VC	Aug 2025	$10M	$41M	Undisclosed	↗

Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Year	Revenue	Growth
2026
2025
2024
2023		—

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Valink Therapeutics website traffic

Latest recorded traffic for Valink Therapeutics is 1.8K monthly website visits, up 12.5% over the last three months. Valink Therapeutics's team grew 14.3% over the past year.

Latest monthly visits1.8K 3-month web change+12.5% 1-year team growth+14.3%

Monthly website visitsDec 2020–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
ARArctorisArctoris is the world's first fully-automated drug discovery data engine, generating valuable insights for biotech and pharma partners	Oxford, United Kingdom	Operational	39	$13M	$11M
PHPharmEnablePharmEnable has developed a rapid and cost effective way to identify better chemical starting points to drive the discovery	Cambridge, United Kingdom	Operational
EXExscientiaApplying artificial intelligence and big data processing to accelerate discovery and development of drugs	Oxford, United Kingdom	Acquired
HEHealxAI-drug discovery accelerating treatments for rare diseases	Cambridge, United Kingdom	Operational
CACardiaTecApplying artificial intelligence on large-scale human multiomic data to develop the next generation of cardiovascular disease targets	Cambridge, United Kingdom	Operational
ADAMPLY DiscoveryNovel Biologics. Designed by Evolution. Discovered by AI	Belfast, United Kingdom	Operational
DEDeepMatterMedical research and development services	Glasgow, United Kingdom	Operational
CDC4X DiscoveryC4X Discovery - building the world's most productive drug discovery engine	Manchester, United Kingdom	Operational